Società Takeda Pharmaceutical Company Limited

4502

JP3463000004

Prodotti farmaceutici

Consensus Analisti

Attività

Vendite per attività

Vendite per regione

Dirigenti

Amministratori

Classe di azioni

Azionisti

Partecipazioni

Coordinate società

Società del gruppo

Settore

Vendite per attività

Vendite per regione

Rating per Takeda Pharmaceutical Company Limited

Revisioni EPS

Utili trimestrali - Indice di sorpresa

Settore Prodotti farmaceutici - Altri

Mercato chiuso - Japan Exchange Altri mercati azionari 08:00:00 17/05/2024			Variaz. 5gg	Var. 1 gen.
4.130 ^JPY	-0,19%		+1,47%	+1,87%

16/05	Takeda Canada completa la fase di LOI per il trattamento post-trapianto del citomegalovirus	MT
15/05	Il vaccino contro la dengue di Takeda Pharmaceutical ha ottenuto la prequalificazione dell'OMS	MT

Takeda Pharmaceutical Company Limited è specializzata nello sviluppo, nella produzione e nella commercializzazione di prodotti farmaceutici, in particolare per le malattie metaboliche e cardiovascolari, i tumori e i disturbi del sistema nervoso centrale. L'attività è organizzata in 2 aree:
- vendita di farmaci e prodotti di consumo;
- servizi.
Le vendite nette sono distribuite geograficamente come segue: Giappone (17,5%), Asia (5%), Stati Uniti (49%), Europa e Canada (20,8%), America Latina (3,8%), Russia e CSI (1,8%) e altro (2,1%).

Numero di dipendenti: 49 095

JPY in Milioni	2022	Peso	2023	Peso	Delta
Gastrointestinal 27,2 %	875 685	24,5 %	1 094 541	27,2 %	+24,99%
Plasma Derivatives (Immune) 16,8 %	506 951	14,2 %	678 443	16,8 %	+33,83%
Neuroscience 15,8 %	482 294	13,5 %	637 711	15,8 %	+32,22%
Other 11,3 %	624 150	17,5 %	454 598	11,3 %	-27,17%
Oncology 10,9 %	468 730	13,1 %	438 742	10,9 %	-6,40%
Rare Genetic Disease and Others 10,4 %	-	-	418 724	10,4 %	-
Rare Hematology 7,6 %	283 689	7,9 %	304 718	7,6 %	+7,41%

JPY in Milioni	2022	Peso	2023	Peso	Delta
United States 52,2 %	1 714 421	48,0 %	2 103 772	52,2 %	+22,71%
Europe and Canada 20,9 %	739 168	20,7 %	842 668	20,9 %	+14,00%
Japan 12,7 %	658 983	18,5 %	512 043	12,7 %	-22,30%
Asia 5,6 %	196 964	5,5 %	225 007	5,6 %	+14,24%
Latin America 4,0 %	128 467	3,6 %	160 375	4,0 %	+24,84%
Other 2,4 %	68 945	1,9 %	95 182	2,4 %	+38,05%
Russia / Commonwealth of Independent States 2,2 %	62 057	1,7 %	88 431	2,2 %	+42,50%

Dirigenti	Titolo	Età	Da
Christophe Weber CEO	Chief Executive Officer	57	01/04/14
Gabriele Ricci CTO	Chief Tech/Sci/R&D Officer	45	01/02/22
Mwana Lugogo CMP	Compliance Officer	54	01/01/12
Michael Mendelsohn CTO	Chief Tech/Sci/R&D Officer	69	01/04/15
Andrew Plump CTO	Chief Tech/Sci/R&D Officer	58	01/02/15
Norimasa Takeda CMP	Compliance Officer	-	-
Constantine Saroukos BRD	Director/Board Member	53	01/01/15
Haruhiko Hirate IRO	Public Communications Contact	-	-
Takashi Okubo IRO	Public Communications Contact	-	-
Christopher O'Reilly IRC	Investor Relations Contact	-	01/06/11

Amministratori	Titolo	Età	Da
Yoshiaki Fujimori BRD	Director/Board Member	71	01/06/16
Ian Clark BRD	Director/Board Member	62	01/01/19
Steven Gillis BRD	Director/Board Member	71	01/01/19
John Maraganore BRD	Director/Board Member	60	01/06/22
Emiko Higashi BRD	Director/Board Member	64	01/06/16
Masami Iijima CHM	Chairman	73	01/06/21
Koji Hatsukawa BRD	Director/Board Member	72	01/06/16
Christophe Weber CEO	Chief Executive Officer	57	01/04/14
Constantine Saroukos BRD	Director/Board Member	53	01/01/15
Kimberly Reed BRD	Director/Board Member	53	01/06/22

	Voto	Quantità	Flottante	Autocontrollo	Flottante totale
Azione A	0	1 582 418 725	1 568 419 964 ( 99,12 %)	13 405 261 ( 0,8471 %)	99,12 %

Nome	Azioni	%	Valorizzazione
BlackRock Fund Advisors 3,496 %	55 319 129	3,496 %	1 460 M ¥
BlackRock Japan Co. Ltd. 2,276 %	36 020 800	2,276 %	951 M ¥
Nikko Asset Management Co., Ltd. 2,194 %	34 711 100	2,194 %	916 M ¥
Nippon Life Insurance Co. 1,564 %	24 752 000	1,564 %	653 M ¥
Takeda Science Foundation 1,132 %	17 912 000	1,132 %	473 M ¥
TAKEDA PHARMACEUTICAL COMPANY LIMITED 0,4747 %	7 511 300	0,4747 %	198 M ¥
BlackRock Investment Management (UK) Ltd. 0,3774 %	5 972 275	0,3774 %	158 M ¥
BlackRock (Netherlands) BV 0,2850 %	4 509 380	0,2850 %	119 M ¥
Takeda Pharmaceutical Employee Incentive Plan 0,2294 %	3 630 339	0,2294 %	96 M ¥
Sumitomo Mitsui Trust Asset Management Co., Ltd. 0,1929 %	3 052 899	0,1929 %	81 M ¥

Nome	Azioni	%	Valorizzazione
Nikko Asset Management Co., Ltd. 2,762 %	87 400 834	2,762 %	1 142 M ¥
Capital Research & Management Co. (Global Investors) 0,4146 %	13 121 930	0,4146 %	172 M ¥
Mondrian Investment Partners Ltd. 0,3817 %	12 079 962	0,3817 %	158 M ¥
Eaton Vance Management 0,1578 %	4 995 623	0,1578 %	65 M ¥
The Ayco Co. LP 0,1330 %	4 209 431	0,1330 %	55 M ¥
Renaissance Technologies LLC 0,0985 %	3 118 200	0,0985 %	41 M ¥
Brandes Investment Partners LP 0,0917 %	2 902 507	0,0917 %	38 M ¥
Fidelity Management & Research Co. LLC 0,0813 %	2 574 240	0,0813 %	34 M ¥
Wells Fargo Bank NA 0,0813 %	2 571 467	0,0813 %	34 M ¥
Millennium Management LLC 0,0734 %	2 322 444	0,0734 %	30 M ¥

Nome	Azioni	%	Valorizzazione
BB Gestão de Recursos DTVM SA 0,000100 %	1 576	0,000100 %	20 546 ¥

Nome	Azioni	%	Valorizzazione
TAKEDA PHARMACEUTICAL COMPANY LIMITED 0.47%	7 511 300	0.47%	198 229 742 $
DENALI THERAPEUTICS INC. 2.96%	4 214 559	2.96%	63 049 803 $
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD. 7.21%	2 204 000	7.21%	32 619 178 $
OVID THERAPEUTICS INC. 12.42%	8 781 996	12.42%	26 258 168 $
PHATHOM PHARMACEUTICALS, INC. 4.77%	2 790 480	4.77%	25 393 368 $
NOILE-IMMUNE BIOTECH INC. 18.76%	8 119 800	18.76%	8 358 928 $
WAVE LIFE SCIENCES LTD. 0.90%	1 096 892	0.90%	5 199 268 $

Takeda Pharmaceutical Co., Ltd.

4-1-1 Dosho-machi Chuo-Ku

540-8645, Osaka

+81 3 3278 2111

http://www.takeda.co.jp

Indirizzo Takeda Pharmaceutical Company Limited(4502)

Nome	Categoria e settore
Shire Biotech India Pvt Ltd.
Takeda Belgium NV Takeda Belgium NV Medical DistributorsDistribution Services Founded in 1835, Takeda Belgium NV is a subsidiary of Takeda Pharmaceutical Co., Ltd. The company is based in Zaventem, Belgium and focuses on providing better healthcare solutions for their patients. Takeda Belgium's mission is centered around the question of how they can do more for their patients.	Medical Distributors
Takeda Pharmaceuticals U.S.A., Inc. Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL.	Pharmaceuticals: Major
Shire Ireland Finance Trading Ltd.
Shire Biotech UK Holdings Ltd. Shire Biotech UK Holdings Ltd. Financial ConglomeratesFinance Part of Takeda Pharmaceutical Co., Ltd., Shire Biotech UK Holdings Ltd. is an investment holding company. Shire Biotech UK Holdings Ltd. is based in London, UK. Founded in 2017, Shire Biotech UK Holdings functions as an investment holding company.	Financial Conglomerates
Takeda A/S Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.	Financial Conglomerates
Takeda Pharmaceuticals International AG Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland.	Pharmaceuticals: Major
Takeda Manufacturing Austria AG Takeda Manufacturing Austria AG Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda Manufacturing Austria AG manufactures and supplies vital medicines and medical devices. The company is based in Vienna, Austria.	Pharmaceuticals: Major
Takeda GmbH Takeda GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Konstanz, Germany. The CEOs are Wolfgang Eck, Uwe Hoffmeister, Roland Kurney. The company was founded in 1873.	Pharmaceuticals: Major
Takeda Austria GmbH Takeda Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Austria GmbH engages in research and development of pharmaceutical products. The company is based in Linz, Austria. Kirsten Detrick has been the CEO of the Austrian company since 2016.	Miscellaneous Commercial Services

Rating Trading

Rating Investimento

ESG Refinitiv

B+

Altri rating

Vendita

Buy

Raccomandazione media

Accumulate

Numero di analisti

Ultimo prezzo di chiusura

4.130 JPY

Prezzo obiettivo medio

4.762 JPY

Differenza / Target Medio

+15,31%

Consenso

Revisioni delle Stime

Calendario della società

Biotecnologia/Farmaceutici

Biotecnologia/Farmaceutici

Prodotti farmaceutici

Prodotti farmaceutici - Altri

	Variaz. 1 gen.	Capi.
TAKEDA PHARMACEUTICAL COMPANY LIMITED	+1,87%	41,81 Mrd
ELI LILLY AND COMPANY	+32,19%	694 Mrd
NOVO NORDISK A/S	+29,39%	593 Mrd
JOHNSON & JOHNSON	-1,57%	371 Mrd
MERCK & CO., INC.	+19,99%	331 Mrd
ABBVIE INC.	+7,20%	290 Mrd
ASTRAZENECA PLC	+14,25%	239 Mrd
ROCHE HOLDING AG	-3,03%	209 Mrd
NOVARTIS AG	+10,02%	209 Mrd
AMGEN INC.	+8,70%	169 Mrd

Prodotti farmaceutici - Altri